IN
Incyte
INCY · NASDAQ
$126.75 +0.23% (+$0.29)
1M +5.13%
Market Cap $25.9B
P/E Ratio 16.09x
Div. Yield -
ROE 29.70%
Bulios Fair Price
$167.69
32.3% upside
Trenutna cena
$126.75
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica INCY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
75 /100
Cheap EV/EBITDA 10.78x
P/S 4.46x
P/B 4.09x
Growth
85 /100
Growing Rev. growth 14.84%
FCF growth 14.94%
Book val. growth 5.75%
Profitability
100 /100
Strong Net margin 27.71%
Op. margin 31.57%
FCF margin 33.00%
Quality
94 /100
Excellent ROE 29.70%
ROA 20.48%
Asset turnover 0.74x
Debt
100 /100
Low Current ratio 4.66x
Int. coverage 847.54x
Net debt/EBITDA -1.93x
Stability
68 /100
Stable Rev. volatility 6.18%
EPS volatility 2,416.72%
Profitable years 5
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INCY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William J. Meury
Employees
2,844
Headquarters
Wilmington
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report